Renal Injury Following Intravitreal Anti-VEGF Administration in Diabetic Patients with Proliferative Diabetic Retinopathy and Chronic Kidney Disease - A Possible Side Effect?

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|9|2|156-158

ISSN： 1574-8863

Source： Current Drug Safety, Vol.9, Iss.2, 2014-07, pp. : 156-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitreous and serum VEGF levels after intravitreal injection of bevacizumab, ranibizumab and triamcinolone acetonide in patients with proliferative diabetic retinopathy

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

The oxygen saturation in retinal arterioles is predictive for the effect of intravitreal anti‐VEGF treatment on diabetic macular edema

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glucose Metabolism, Insulin Resistance, and Renal Pathology in Non-Diabetic Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 108, Iss. 2, 2008-02 ,pp. : c163-c168

Karger

Access to resources Recommend Favorite

Gender‐ and disease‐specific urinary thioredoxin in chronic kidney disease patients with or without type 2 diabetic nephropathy

By  

NEPHROLOGY, Vol. 20, Iss. 5, 2015-05 ,pp. : 368-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Choroidal thickness in diabetic patients without diabetic retinopathy

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite